GA
Gunja Ashish Pandey
About Gunja Ashish Pandey
Data last updated:
Gunja Ashish Pandey is a Director at Purecure Biotech (Opc) Private Limited (since 2026) and Director at Otitis Rabnew Pharma Private Limited (since 2018). The companies operate in Business Services.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Purecure Biotech (Opc) Private Limited U47721MR2026OPC479792 | Director | 14 Aug 2026 | 2026 | Active | |
| Otitis Rabnew Pharma Private Limited U74999MH2018PTC305432 | Director | 15 Dec 2018 | 2018 | Active |
Board colleagues of Gunja Ashish Pandey
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ashish Chhotelal Pandey | 08058495 | Purecure Biotech (Opc) Private Limited | Nominee |
| Ganesh Sambhaji Kale | 08058469 | Otitis Rabnew Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Gunja Ashish Pandey
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gunja Ashish Pandey
Gunja Ashish Pandey currently holds 2 directorships: Purecure Biotech (Opc) Private Limited (Director, since 14 Aug 2026); Otitis Rabnew Pharma Private Limited (Director, since 15 Dec 2018).
Gunja Ashish Pandey was first appointed on 15 Dec 2018 as Director at Otitis Rabnew Pharma Private Limited. The most recent appointment on record is 14 Aug 2026 at Purecure Biotech (Opc) Private Limited.
The current boards of Gunja Ashish Pandey's companies include Ashish Chhotelal Pandey (Purecure Biotech (Opc) Private Limited), Ganesh Sambhaji Kale (Otitis Rabnew Pharma Private Limited).